Codiak BioSciences

$13.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$2.06 (-13.02%) As of 4:48 PM UTC today

Why Robinhood?

You can buy or sell CDAK and other stocks, options, and ETFs commission-free!

About CDAK

Codiak BioSciences, Inc. engages in the development and manufacturing of exosomes. It engages in harnessing exosomes, therapeutic applications, diagnostic applications, and proprietary production. The firm develops engEx Platform, a proprietary and versatile exosome engineering and manufacturing platform, to expand upon the innate properties of exosomes to design novel exosome therapeutics. The company was founded by Douglas E. William, Raghu Kalluri, and Eric S. Lander in 2015 and is headquartered in Cambridge, MA. The listed name for CDAK is Codiak BioSciences, Inc. Common Stock.

CEO
Douglas E. Williams
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2015
Market Cap
340.12M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
153.03K
High Today
$16.02
Low Today
$13.56
Open Price
$16.02
Volume
52.99K
52 Week High
$37.85
52 Week Low
$7.90

CDAK Earnings

-$12.83
-$8.55
-$4.28
-$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 22, After Hours

You May Also Like

JJM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure